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Sir2, an evolutionarily conserved NAD+-dependent
deacetylase, has been implicated as a key factor
in mediating organismal life span. However, recent
contradictory findings have brought into question
the role of Sir2 and its orthologs in regulating or-
ganismal longevity. In this study, we report that
Drosophila Sir2 (dSir2) in the adult fat body regulates
longevity in a diet-dependent manner. We used in-
ducible Gal4 drivers to knock down and overexpress
dSir2 in a tissue-specific manner. A diet-dependent
life span phenotype of dSir2 perturbations (both
knockdown and overexpression) in the fat body,
but not muscles, negates the effects of background
genetic mutations. In addition to providing clarity to
the field, our study contrasts the ability of dSir2 in
two metabolic tissues to affect longevity. We also
show that dSir2 knockdown abrogates fat-body
dFOXO-dependent life span extension. This report
highlights the importance of the interplay between
genetic factors and dietary inputs in determining
organismal life spans.
INTRODUCTION
Organismal life span is a complex phenotype and is regulated by
various genetic and environmental factors. Among these factors,
metabolic sensors that govern organismal physiology are crucial
for coupling nutritional or dietary inputs with longevity. Different
strains and species respond to dietary cues differently (Gelegen
et al., 2006) and therefore exhibit varied diet-dependent lon-
gevity phenotypes (Bauer et al., 2010; Kwan et al., 2011; Tamura
et al., 2011). In spite of such variations, genetic perturbations of
key factors have led to the identification of mechanisms that
regulate longevity (Clancy et al., 2001; Lin et al., 1998; Tatar
et al., 2001). Background geneticmutations (in laboratory strains)
that could contribute to the phenotype are also a concern. How-
ever, with the advent of inducible expression systems (Oster-
walder et al., 2001; Roman et al., 2001) in which both the control
and genetically perturbed (induced overexpression, knockdown,
or knockout) cohorts have similar backgrounds, some of these
concerns can be successfully addressed.Cell ReSirtuins, or Sir2-like proteins, are NAD+-dependent enzymes
that link cellular physiology with metabolic changes (Bishop
and Guarente, 2007; Ghosh et al., 2010; Imai et al., 2000; Longo
and Kennedy, 2006). Sir2 was identified as a key determinant of
longevity in Saccharomyces cerevisiae (Delaney et al., 2011;
Kaeberlein et al., 1999). Its dependence on NAD+ for its activity
is crucial for its ability to link caloric/dietary restriction (CR/DR)
with life span extension (Anderson et al., 2003; Balan et al.,
2008; Delaney et al., 2011; Gallo et al., 2004; Imai et al., 2000;
Kaeberlein et al., 1999). Initial observations in Caenorhabditis
elegans (Tissenbaum and Guarente, 2001) and Drosophila mela-
nogaster (Rogina and Helfand, 2004; Bauer et al., 2009) indi-
cated the evolutionary significance of Sir2 in extending life
span. However, recent contradictory findings about the role
of Sir2 in regulating longevity in metazoans have raised concerns
about confounding background geneticmutations (Burnett et al.,
2011; Viswanathan and Guarente, 2011).
Components of insulin IGF-1 signaling (IIS), which include the
effector transcription factor FOXO, regulate life span (Clancy
et al., 2001;Giannakou et al., 2004;Hwangboet al., 2004;Kenyon
et al., 1993; Murphy et al., 2003; Tatar et al., 2001). Studies in
Drosophila showed that inducible overexpression of dFOXO
(both wild-type and the constitutively nuclear form) results in
life span extension (Giannakou et al., 2004; Hwangbo et al.,
2004).
Studies in mammalian SIRT1 and our work on dSir2 in flies
(Banerjee et al., 2012a, 2012b) have established that Sir2 and
its orthologs play a crucial role in metabolic homeostasis and
IIS (Liang et al., 2009; Schenk et al., 2011; Zhang, 2007). We
have previously shown that functions of dSir2 in the fat body
are required for maintaining the metabolic regulatory network
across the organism and are crucial for survival during starvation
(Banerjee et al., 2012a, 2012b).
In vivo Sir2/SIRT1 activity is intrinsically coupled to changes
in the levels of NAD+ (Anderson et al., 2003; Gallo et al., 2004;
Imai et al., 2000; Nakahata et al., 2008; Vaziri et al., 2001; Zhang
et al., 2009). Several studies have established that dietary alter-
ations and aging, which increase or decrease cellular NAD+
levels, affect Sir2/SIRT1 activity in vivo (Anderson et al., 2003;
Gallo et al., 2004; Imai et al., 2000; Nakahata et al., 2008; Vaziri
et al., 2001; Zhang et al., 2009).
Here, we address the role of dSir2 in longevity using
Drosophila as a model system. To circumvent the concerns
about background genetic effects, we employed an inducible
gene-switch system to overexpress and knock down dSir2ports 2, 1485–1491, December 27, 2012 ª2012 The Authors 1485
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Figure 1. Diet-Dependent Effect of dSir2
Knockdown on Longevity
(A and B) Life spans of control (pSw-tub-Gal4 >
Sir2RNAi  RU486) and whole-body dSir2 knock-
down (pSw-tub-Gal4 > Sir2RNAi + RU486) flies on
diets containing varying amounts (0.25%, 2.5%,
and 5%) of yeast (n = 100). The median life spans
of control flies on standard and restricted diets
were 41.1 (±2.2) and 50.2 (±1.8) days, respectively.
The median life spans of whole-body dSir2
knockdown flies on standard and restricted diets
were 39.3 (±0.5) and 40.4 (±1.3) days, respectively.
The median life spans of control and dSir2
knockdown flies on high-yeast diets were 31.9
(±3.1) and 32.8 (±2.9) days, respectively.
(C and D) dSir2 protein levels under 2.5% Y and
0.25% Y diets.
(E) Intracellular NAD+ levels from flies reared on
diets containing varying amounts of yeast. Mantel-
Cox (log-rank) regression analyses were used
for life span assays. All data are indicated as
the mean ± SEM; *p < 0.05, **p < 0.01, and
***p < 0.001.
See also Figures S1 and S4.expression in a tissue-specific manner. Our results clearly
demonstrate that dSir2 in the fat body, but not in muscles, medi-
ates life span extension in a diet-dependent manner.
RESULTS
Whole-Body dSir2 Knockdown Abrogates Life Span
Extension in a Diet-Dependent Manner
To determine whether dSir2 plays any role in regulating life span,
we knocked down its expression in the whole body (pSw-tub-
Gal4 > Sir2RNAi). Control (RU486) flies on yeast-restricted diets
(DR: 8.6% cornmeal [CM], 5.0% sucrose [S], 0.25% yeast [Y])
displayed a longevity phenotype that is well established in the1486 Cell Reports 2, 1485–1491, December 27, 2012 ª2012 The Authorsfield (Figures 1A and 1B). Whole-body
dSir2 knockdown (+RU486) flies did not
show the life span extension that the
control flies exhibited under DR (Figures
1A and 1B).
Intriguingly, the dSir2-dependent life-
span phenotype was observed only
when the flies were shifted from media
containing 2.5% yeast to that with
0.25% yeast (Figures 1A and 1B). When
flies were grown on a diet containing
high yeast (5.0%), both control (RU486)
and dSir2 knockdown (+RU486) flies
behaved similarly and had shorter survival
times than the control flies on a normal
diet (2.5% yeast; Figures 1A and 1B).
dSir2 Expression and Intracellular
NAD+ Levels Increase during DR
Because knockdown of dSir2 elicited
a response only upon yeast restriction,we wanted to ascertain whether this dependence was due to
changes in dSir2 expression. We observed an increase in dSir2
expression under yeast-restricted conditions (Figures 1C, 1D,
S1A, and S1D).
Because increased NAD+ levels have been associated with
enhanced Sir2 activity in vivo (Anderson et al., 2003; Gallo
et al., 2004; Imai et al., 2000; Nakahata et al., 2008; Vaziri
et al., 2001; Zhang et al., 2009), we speculated that the dSir2-
mediated longevity phenotype would be evident on diets that
increased NAD+ levels. Intracellular NAD+ levels increased under
yeast-restricted conditions (1.0% and 0.25% yeast) and did
not change between diets containing 2.5% and 5.0% yeast
(Figure 1E). The increase in dSir2 expression (Figures 1C, S1A,
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Figure 2. Knocking Down dSir2 in the Fat
Body, but Not in Muscles, Affects Diet-
Dependent Life Span Extension
(A and B) Life spans of control (pSw-S1106-Gal4 >
Sir2RNAi  RU486) and fat-body dSir2 knockdown
(pSw-S1106-Gal4 > Sir2
RNAi + RU486) flies on
diets containing varying amounts (0.25%, 2.5%,
and 5%) of yeast (n = 100). The median life spans
of control flies on standard and restricted diets
were 36.9 (±1.28) and 47.6 (±1.05) days, respec-
tively. The median life spans of fat-body dSir2
knockdown flies on standard and restricted diets
were 36.1 (±2.18) and 35.7 (±1.5) days, respec-
tively. The median life spans of control and fat-
body dSir2 knockdown flies on high yeast diets
were 30.8 (±2.06) and 28.4 (±1.17) days, respec-
tively.
(C and D) Life spans of control (pSw-MHC-Gal4 >
Sir2RNAi  RU486) and muscle dSir2 knockdown
(pSw-MHC-Gal4 > Sir2RNAi + RU486) flies on diets
containing 0.25% and 2.5% yeast (n = 100). The
median life spans of control and muscle dSir2
knockdown flies were 37.8 (±3.11) and 35.9 (±4.16)
days, respectively, on the standard diet, and 50.3
(±2.3) and 51.3 (±1.5) days, respectively, on yeast-
restricted diets. Mantel-Cox (log-rank) regression
analyses were used for life span assays. All data
are indicated as the mean ± SEM; *p < 0.05, **p <
0.01, and ***p < 0.001.
See also Figures S1, S2, and S3.and S1D) and NAD+ levels (Figure 1E) indicates that the functions
of dSir2 are maximal under yeast restriction.
dSir2 in the Fat Body, but Not inMuscles, Mediates Diet-
Dependent Life Span Extension
The functions of metabolic sensors/regulators in the adult fat
body have been reported to be important for organismal homeo-
stasis and life span (Arrese and Soulages, 2010; DiAngelo and
Birnbaum, 2009). Consistent with this, earlier work from our
laboratory showed that the functions of dSir2 in the adult fat
body are crucial for maintaining metabolic homeostasis, IIS,
andmitochondrial functions in the rest of the organism (Banerjee
et al., 2012b). Knockdown and overexpression of dSir2 in the fat
body also affected starvation resistance (Banerjee et al., 2012b).
Motivated by these findings, we wanted to ascertain whether
dSir2 in metabolically relevant tissues (i.e., the adult fat body
and muscles) regulated a diet-dependent life span extension.
Knocking down dSir2 in the fat body (pSw-S1106-Gal4 >
Sir2RNAi +RU486) had no effect on longevity under normal die-
tary conditions (Figures 2A, 2B, S1B, and S1E). Life spanCell Reports 2, 1485–1491, Deextension under yeast-restricted condi-
tions was abrogated when dSir2 was
knocked down in the fat body (Fig-
ures 2A and 2B) and phenocopied
the whole-body dSir2 knockdown flies
(pSw-tub-Gal4 > Sir2RNAi; Figures 1A
and 1B). Fat-body-specific knockdown
of dSir2 did not affect life span on the
high-yeast diet (Figures 2A and 2B),similar to what was observed for the whole-body phenotype
(Figures 1A and 1B).
On the contrary, there was no effect of knockdown of dSir2 in
the muscles (pSw-MHC-Gal4 > Sir2RNAi ) on a yeast-restricted
diet (Figures 2C, 2D, S1C, and S1F). The median and maximum
life spans were comparable between control (RU486) and
dSir2 knockdown (+RU486) flies under both 2.5% and 0.25%
yeast conditions (Figures 2C and 2D).
dSir2 Overexpression in the Fat Body Results in
a Longevity Phenotype
We overexpressed dSir2 using tissue-specific inducible Gal4
drivers (pSw-S1106-Gal4 and pSw-MHC-Gal4) and dSir2
EP2300
flies (Figures 3A, 3B, 3G, 3H, and S2). There was no difference
in expression of the DNAJ-H gene (Griswold et al., 2008), which
has been one of the concerns associated with dSir2EP2300 flies
(Figure S3). In contrast to previous studies (Burnett et al.,
2011), we were able to upregulate dSir2 expression to an extent
similar to that observed in control flies under yeast-restricted
conditions (Figures 3A, 3B, 3G, and 3H) in the fat bodies.cember 27, 2012 ª2012 The Authors 1487
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Figure 3. Overexpression of dSir2 in the Fat
Body, but Not in Muscles, Extends Life Span
(A) dSir2 expression in the fat body of control
and fat-body dSir2-overexpressing flies under the
2.5% Y diet.
(B) dSir2 expression in the fat body of control flies
under 2.5% Y and 0.25% Y diets.
(C and D) Life spans of control (pSw-S1106-Gal4 >
Sir2EP2300  RU486) and fat-body dSir2 over-
expression (pSw-S1106-Gal4 > Sir2
EP2300 +
RU486) flies on diets containing 0.25% and 2.5%
yeast (n = 100). The median life spans of control
and fat-body-specific dSir2 overexpression flies
were 32.6 (±2.1) and 43.1 (±2.47) days respectively
on the normal diet, and 43.8 (±1.8) and 43.7 (±2.3)
days on the yeast-restricted diet.
(E and F) Life spans of control (pSw-MHC-Gal4 >
Sir2EP2300  RU486) and muscle-specific dSir2
overexpression (pSw-MHC-Gal4 > Sir2EP2300 +
RU486) flies on diets containing 0.25% and 2.5%
Y (n = 100). The median life spans of control and
muscle-specific dSir2 overexpression flies on the
standard diet were respectively 33.2 (±3.8) and
32.1 (±2.8) days on the standard diet, and 42.5
(±1.72) and 43.02 (±3.1) days on the restricted diet.
(G and H) Relative messenger RNA (mRNA) levels
of dSir2 in the fat body (G) and muscles (H) of
control and tissue-specific dSir2 overexpression
flies under 2.5% Y and 0.25% Y diets (n = 24 flies).
Mantel-Cox (log-rank) regression analyses were
used for life span assays. All data are indicated
as the mean ± SEM; *p < 0.05, **p < 0.01, and
***p < 0.001.
See also Figures S1, S2, S3, and S4.Assays for longevity clearly indicated that dSir2 overexpres-
sion in the adult fat body extended life span on a standard diet
and there was no further increase in response to yeast restriction
(Figures 3C and 3D). Corroborating the knockdown results, we
did not find any life span increase when dSir2 was overex-
pressed in the muscles (Figures 3E and 3F). Both control and
muscledSir2overexpression flies phenocopied each other under
normal and yeast-restricted conditions (Figures 3E and 3F).
dSir2 Knockdown Abrogates dFOXO-Dependent Life
Span Extension
FOXO transcription factors are key players in mediating meta-
bolic and stress responses (Barthel et al., 2005; Gross et al.,1488 Cell Reports 2, 1485–1491, December 27, 2012 ª2012 The Authors2008). To determine whether the dSir2-
dFOXO interplay is important for organ-
ismal life span, we overexpressed the
constitutively nuclear (active) dFOXO
(dFOXO-TM) alone (pSw-S1106-Gal4 >
dFOXO-TMOE) or in the background of
dSir2 knockdown (pSw-S1106-Gal4 >
dSir2RNAi+FOXO-TMOE) in the adult fat
body. Overexpression of dFOXO-TM in
the adult fat body resulted in life span
extension (Figures 4A and 4C). This lon-
gevity phenotype was abrogated whendSir2 was knocked down simultaneously in the same tissue
(Figures 4B and 4C).
DISCUSSION
The ability of genetic factors to regulate organismal life span is
well established across model organisms. However, it is still
not clear whether their perturbationswould lead to similar pheno-
types across dietary regimes and strains. Genetic variations and
dietary inputs (and perception) are likely to alter complex pheno-
types such as longevity. However, life span studies across
species have been instrumental in revealing the genetic mecha-
nisms that mediate organismal survival and dietary inputs.
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(8.6% CM, 5.0% S)B Figure 4. Fat-Body dFOXO-TM-DependentLife Span Extension Is Abrogated when
dSir2 Is Knocked Down
(A) Lifespansofcontrol (pSw-S1106-Gal4>dFOXO-
TM  RU486) and fat-body-specific dFOXO-TM
overexpression (pSw-S1106-Gal4 > dFOXO-TM +
RU486) flies on diets containing 2.5% Y (n = 100).
(B) Life span assay of control (pSw-S1106-Gal4 >
dFOXO-TM + Sir2RNAi  RU486) and fat-body
dFOXO-TM overexpression with simultaneous
dSir2 knockdown (pSw-S1106-Gal4 > dFOXO-
TM + Sir2RNAi + RU486) flies on diets containing
2.5% Y (n = 100).
(C) Median life spans for (A) control (pSw-S1106-
Gal4 > dFOXO-TM  RU486) and fat-body-
specific dFOXO-TM overexpression (pSw-S1106-
Gal4 > dFOXO-TM + RU486) flies were 34.3
(±1.15) and 44.2 (±2.83) days, respectively.
Median life spans for (B) control (pSw-S1106-
Gal4 > dFOXO-TM + Sir2RNAi  RU486) and fat-
body-specific dFOXO-TM overexpression with a
simultaneous knockdown of dSir2 (pSw-S1106-
Gal4 > dFOXO-TM + Sir2RNAi + RU486) were 36.7
(±2.6) and 33.9 (±3.12) days, respectively. Mantel-
Cox (log-rank) regression analyses were used
for life span assays. All data are indicated as
the mean ± SEM; *p < 0.05, **p < 0.01, and
***p < 0.001.
See also Figure S4.Here, we addressed the role of dSir2 in regulating organismal
life span. Furthermore, by rearing the flies on diets that contained
varied amounts of yeast but constant amounts of cornmeal and
sucrose (8.6% and 5.0%, respectively), we negated the effects
of medium dilution. Our results clearly demonstrate that knock-
ing down dSir2 in the whole body abrogates the yeast-restriction
(0.25% yeast)-dependent life span extension. Knocking down
dSir2 in the fat body, but not in the muscles, phenocopied the
longevity of whole-body dSir2 knockdown flies (Figures 1 and
2). Furthermore, our findings illustrate that the dSir2-mediated
longevity phenotype is highly dependent on dietary inputs,
because abrogating fat-body dSir2 expression did not alter the
life span when flies were reared on 2.5% and 5.0% yeast-con-
taining diets (Figure 1).
To confirm the role of dSir2 on organismal life span, we also
overexpressed it in both the fat body and muscles. Consistent
with the results obtained from dSir2 knockdown flies, its overex-
pression in the fat body, but not in muscles, led to a longevity
phenotype in flies reared on a standard diet (2.5% Y, 5.0% S,
and 8.6% CM; Figure 3). We did not observe an additive pheno-
type when flies overexpressing dSir2 in the fat body were reared
on a yeast-restricted diet (0.25%yeast). Both control andmuscle
dSir2 overexpression flies responded similarly to dietary pertur-
bations, indicating that its overexpression in this tissue does not
increase the life span (Figure 3).Cell Reports 2, 1485–1491, DeMoreover, the diet dependence of the
dSir2-mediated longevity phenotype can
be explained by an increase in the ex-
pression of dSir2 under yeast-restricted
conditions (Figure 1). Furthermore, ourresults show that intracellular NAD+ levels also increase when
the yeast content is reduced (Figure 1). Several studies in
mammals and flies have indicated the importance of NAD+ in
Sir2 functions (Anderson et al., 2003; Balan et al., 2008; Delaney
et al., 2011; Gallo et al., 2004; Imai et al., 2000; Kaeberlein et al.,
1999). In the absence of an in vivo assay for Drosophila sirtuins,
alterations in intracellular NAD+ levels are considered to reflect
their activities and functional outputs.
Unlike starvation, which usually kills an organism, decreasing
the yeast content (keeping sucrose constant) has been specu-
lated to evoke a DR response in flies (Mair et al., 2005; Min
et al., 2007). In this respect, it is important to note that previous
work from our laboratory showed that dSir2 knockdown and
overexpression results in reduced and enhanced starvation
survival, respectively (Banerjee et al., 2012a, 2012b), which is
bidirectional and distinct from the phenotype reported in this
study.
The possible simultaneous overexpression of the DNAJ-H
gene (adjacent to the dSir2 gene) has been a major concern in
interpreting the effects of dSir2 overexpression on longevity
(Griswold et al., 2008). However, using the inducible gene-switch
system, we clearly show that under the conditions we employed,
there was no induction of the DNAJ-H gene (Figure S3).
Importantly, the extent of dSir2 overexpression was very
similar to the increase of the endogenous protein in control fliescember 27, 2012 ª2012 The Authors 1489
under yeast restriction (Figures 1, 3, S1, and S2) and is therefore
physiologically relevant. In previous studies, the dSir2 expres-
sion might not have been physiologically relevant, because the
extent of overexpression varied depending on the controls that
were used for comparison, or were too high (Burnett et al.,
2011; Griswold et al., 2008). Different tissues are known to
respond differently to DR. In this respect, overexpression of
a metabolic regulator in a metabolic tissue becomes relevant
when addressing a diet-dependent change in longevity.
A recent study by Burnett et al. (2011) has raised concerns
about background mutations that might be responsible for
the previously observed dSir2-dependent extension of life
span. In our report, we have negated the effects of back-
ground genetic mutation by employing inducible Gal4 drivers
to knock down and overexpress dSir2 in a tissue-specific
manner. Specifically, it is unlikely that a background muta-
tion would mediate diet-dependent and bidirectional changes
(when dSir2 is overexpressed and knocked down) in both
whole-body- and fat-body-specific perturbations. We observed
a conservation of dSir2-dependent changes in a tissue-specific
manner even though the parent lines were obtained from dif-
ferent sources. The absence of a dSir2-dependent phenotype
when its expression is perturbed in the muscles also rules
out the contribution of a background genetic mutation. To
summarize, a background mutation is unlikely to behave in a
diet-dependent and tissue-specific manner mirroring the dSir2
phenotype.
IIS-mediated alterations in FOXO activity have been shown
to be a major determinant of organismal life span. Previous
studies using the same gene-switch systems employed here
showed that overexpression of dFOXO in the adult fat body
extended life span (Giannakou et al., 2004; Hwangbo et al.,
2004), highlighting its functions in ametabolically relevant tissue.
Our recent findings (Banerjee et al., 2012b) and the current
results emphasize the importance of dSir2-dFOXO interactions
in the adult fat body for mediating organismal physiology and
longevity.
DR-dependent extension of life spans has been ascribed to
a reduction in the initial mortality rate (age-independent mortality
parameter) rather than the rate of aging (age-dependent mor-
tality parameter) (Partridge et al., 2005). Consistent with earlier
reports, we also observed a significant decrease in the age-inde-
pendent mortality rates when flies were subjected to DR (Tables
S2 and S3; Figure S4). Whereas knockdown of dSir2 abolished
the effect of DR on mortality, overexpression of dSir2 mimicked
DR. Interestingly, the effects of dSir2 perturbations on longevity
were mainly mediated by alterations in age-independent mor-
tality rates. These findings further support the hypothesis that
dSir2 mediates DR-dependent life span extension in flies and
that its overexpression mimics DR.
To conclude, we have demonstrated that dSir2 in the fat
body, but not in muscles, regulates longevity in a diet-depen-
dent manner. Our results also show that dSir2 is important for
dFOXO-dependent longevity. This study not only addresses
the controversy associated with Sir2-dependent longevity but
also highlights the importance of dSir2 in metabolically relevant
tissues for eliciting a complex phenotype such as organismal
aging.1490 Cell Reports 2, 1485–1491, December 27, 2012 ª2012 The AutEXPERIMENTAL PROCEDURES
Fly Strains
P{Switch1}106 and Sir2-EP2300 were obtained from the Bloomington Stock
Center, Indiana University. dSir2RNAi (CG5216:23201/GD) was obtained from
the Vienna Drosophila RNAi Center (VDRC). P{Switch} tubulin Gal4 and
yw+;UAS-dFOXO-TM (dFOXOAAA) flies were kind gifts from Dr. Stephen Hel-
fand and Dr. Marc Tatar, respectively. rp298;P{Switch-MHC}-Gal4 was ob-
tained from theNational Centre for Biological Sciences (Bangalore, India). Flies
were grown on normal food under noncrowding conditions and a 12 hr light/
12 hr dark cycle at 25C.
Fly Diets
Diets containing different amounts of yeast extract (0.25%, 2.5%, and 5.0%)
with 5% sucrose and 8.6% cornmeal were used for life span assays.
dSir2 Knockdown and Overexpression
Gal4 was activated by rearing flies on diets that contained 200 mM RU486
(Mifepristone; Sigma-Aldrich), which was dissolved in ethanol. For experi-
ments with pSw-S1106-Gal4 > fbdSir2
KD+FOXO-TMOE, 400 mM RU486 was
used to activate Gal4. Flies reared on diets that contained ethanol alone
were used as controls.
Life Span Assay
Female flies were maintained in vials at a density of ten flies per vial, with ten
vials used per assay/diet. Flies were transferred to new vials on alternate days,
and dead flies were scored during every transfer.
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures, three tables, and Extended
Experimental Procedures and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2012.11.013.
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